down arrow

Zydus Wellness

  • Market Cap: Mid Cap
  • Industry: FMCG
  • ISIN: INE768C01010
  • NSEID: ZYDUSWELL
  • BSEID: 531335
INR
1,750.80
12.8 (0.74%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 25.25 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Zydus Wellness Ltd stock-summary
stock-summary
Zydus Wellness Ltd
Mid Cap
FMCG
Headquartered in Ahmedabad, Zydus Wellness operates as an integrated consumer Company with business encompassing the entire value chain in the development, production, marketing and distribution of health and wellness products. The Company's product portfolio includes popular brands with functional benefits like Glucon D, Complan, Sugar Free, Nycil, Everyuth, Nutralite and Sugarlite.
Company Coordinates stock-summary
Company Details
Zydus Corporate Park S No 536, Sarkhej-Gandhinagar Highway Ahmedabad Gujarat : 382481
stock-summary
Tel: 91-79-67775888
stock-summary
investor.grievance@zyduswellness.in
Registrar Details
Link Intime India Pvt Ltd., UnitNo. 303, 3rd Floor, Shoppers Plaza V, Opp. Municipal Market, B/h. Shoppers Plaza II, Off. C. G. Road,, Ahmedabad
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR 63.63 Cr
Number of Shares
6.36 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
28-Sep-2020
6.36
63.63
3846000
10
Qualified Institutional Placement
29-Jan-2019
5.77
57.66
18592055
10
Allotment of Equity To Others
17-Jan-2009
3.91
39.07
33496989
10
DeMerger
17-Jan-2009
3.91
39.07
33496989
10
DeMerger
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 14 Schemes (11.87%)

FIIs

Held by 99 FIIs (3.37%)

Promoter with highest holding

Zydus Lifesciences Limited (57.59%)

Highest Public shareholder

Threpsi Care Llp (7.27%)

Individual Investors Holdings

5.56%

stock-summary Board of Directors
stock-summary
stock-summary
Management
Designation
Remuneration
Ganesh N Nayak
Non-Exec & Non-Independent Dir
12.0 lacs
Sharvil P Patel
Chairman (Non-Executive)
8.0 lacs
Tarun Arora
Whole Time Director & CEO
1.25 cr
Kulin S Lalbhai
Non-Exec. & Independent Dir.
17.0 lacs
Ashish Bhargava
Nominee
0
Dharmishta N Rawal
Non-Exec. & Independent Dir.
14.0 lacs
Srivishnu Raju Nandyala
Non-Exec. & Independent Dir.
17.0 lacs
Nandish P. Joshi
Company Sec. & Compli. Officer
0
Akhil A. Monappa
Independent Director
0
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
 
Icon
No Data Available
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Consumer Products
159.65
62.70%
Other Operating Income - Share of Profit from the Partnership Firm
94.42
37.08%
Other Operating Income - Miscellaneous Income
0.49
0.19%
 
62.7
Consumer Products
37.3
Consumer Products
37.08
Other Operating Income - Share of Profit from the Partnership Firm
62.92
Other Operating Income - Share of Profit from the Partnership Firm
0.19
Other Operating Income - Miscellaneous Income
99.81
Other Operating Income - Miscellaneous Income
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
462 Cr
(Quarterly Results - Dec 2024)
Net Profit:
6 Cr
stock-summary
Industry

FMCG

stock-summary
Market cap

INR 11,141 Cr (Mid Cap)

stock-summary
P/E

35.00

stock-summary
Industry P/E

54

stock-summary
Dividend Yield

0.29%

stock-summary
Debt Equity

-0.04

stock-summary
Return on Equity

5.72%

stock-summary
Price to Book

2.01